This book investigates the commercialization processes of biotechnology by analyzing how scientific knowledge is transformed into market-ready products. Maureen D. McKelvey, an expert in the economics of innovation, utilizes a comparative framework to examine the organizational strategies and developmental trajectories of two distinct firms. By focusing on the production of insulin and human growth hormone, the author argues that innovation is an evolutionary process shaped by institutional environments and firm-specific capabilities.

Experts recognize this work as a foundational text for understanding the intersection of biotechnology and industrial organization. Readers frequently note the academic density of the prose, which provides a rigorous look at the institutional factors influencing modern science-based industries.